Fig. 4From: N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancerA Clinical features (including TNM staging, early (IA-IIA) and late (IIB-IVB) FIGO staging, histological grading, age > 50 years/ < 50 years, and clusters 1/2). Analysis of immune cell infiltration in CESCs. B Violin plots of immune cell differences between clusters 1/2. C Box plots of immune cell differences between clusters 1/2, where blue represents cluster 1 and red represents cluster 2. D Results of CESC gene set enrichment analysis (GSEA)Back to article page